Vincent Cottin

62.6k citations

524 papers · 19.4k indexed · 16 hit papers · h-index 72

Impact in

Pulmonary and Respiratory Medicine top 0.02%
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Pulmonary Hypertension Research and Treatments
- Medical Imaging and Pathology Studies
- Chronic Obstructive Pulmonary Disease (COPD) Research
Physiology top 0.2%
- Sarcoidosis and Beryllium Toxicity Research

Papers in

Pulmonary and Respiratory Medicine 442
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis 338
- Pulmonary Hypertension Research and Treatments 101
- Medical Imaging and Pathology Studies 51
- Chronic Obstructive Pulmonary Disease (COPD) Research 48
Physiology 144
- Sarcoidosis and Beryllium Toxicity Research 106

Co-authors: Jean-François Cordier Athol U. Wells Luca Richeldi Marlies Wijsenbeek Kevin K. Brown Susanne Stowasser Toby M. Maher Rozsa Schlenker‐Herceg
Journals: European Respiratory Journal (54 papers)Respiration (23 papers)American Journal of Respiratory and Critical Care Medicine (18 papers)ERJ Open Research (15 papers)European Respiratory Review (14 papers)
Partner nations: France United States United Kingdom

In The Last Decade

Vincent Cottin

484 papers receiving 19.1k citations

Hit Papers

15 papers align trajectories log scale

Nerandomilast in Patients with Idiopathic Pulmonary Fibrosis 2025 · 28 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2025 New England Journal of Medicine
2025 New England Journal of Medicine
2022 New England Journal of Medicine
2020 New England Journal of Medicine
2020 The Lancet Respiratory Medicine
2019 New England Journal of Medicine
2019 European Respiratory Review
2019 Nature Reviews Disease Primers
2019 The Lancet Respiratory Medicine
2018 European Respiratory Review
2017 European Respiratory Journal
2016 Respiratory Medicine
2015 European Respiratory Journal
2013 Journal of the American College of Cardiology
2013 Journal of the American College of Cardiology
2005 European Respiratory Journal

Peers

Countries citing papers authored by Vincent Cottin

Since Specialization

Citations

This map shows the geographic impact of Vincent Cottin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vincent Cottin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vincent Cottin more than expected).

Fields of papers citing papers by Vincent Cottin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vincent Cottin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vincent Cottin. The network helps show where Vincent Cottin may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Vincent Cottin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Vincent Cottin Line = papers co-authored together Vincent Cottin links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	TETON-PPF Clinical Trial of Inhaled Treprostinil for the Treatment of Progressive Pulmonary Fibrosis: Preliminary Baseline Demographics American Journal of Respiratory and Critical Care Medicine ·Brigitte Holten, Lesly Franco Deloya, Vincent Cottin, Inês Miguel Grave da Gama Ferreira, Zahra Mehdizadeh-Somarin, 硫安協会, Yonglin Zheng, Tota Fierda Ria Angelina Simbolon, Leigh Peterson, Kevin R. Flaherty	2025	0
2	Electronic Nose Technology as Diagnostic Tool for Different Fibrotic Interstitial Lung Disease: The ILDnose Study American Journal of Respiratory and Critical Care Medicine ·Aracy Bellas Campo, Catharina C. Moor, 葛城直哉, H.R.A. De Mey, Markus Polke, Michael Kreuter, Vincent Cottin, Philip L. Molyneaux, 王增富	2025	0
3	Circulating biomarkers and progression of idiopathic pulmonary fibrosis: data from the INMARK trial ERJ Open Research ·Toby M. Maher, Gísli Jenkins, Vincent Cottin, Yasuhiko Nishioka, Imre Noth, Moisés Selman, Jin Woo Song, Carina Ittrich, Quynh Vo, Susanne Stowasser, Eric S. White	2024	3
4	Identification of progressive pulmonary fibrosis: consensus findings from a modified Delphi study Respiratory Research ·Athol U. Wells, Simon Walsh, Ayodeji Adegunsoye, Vincent Cottin, Sonye K. Danoff, Anand Devaraj, Kevin R. Flaherty, Peter M. George, Kerri A. Johannson, Martin Kolb, Yasuhiro Kondoh, Andrew G. Nicholson, Sara Tomassetti, Elizabeth R. Volkmann, Kevin K. Brown	2024	3
5	Evaluation of efficacy and safety of rituximab in patients with progressive interstitial lung disease (ILD) with inflammatory component (EvER-ILD2): A multicentre double-blind placebo-controlled randomized trial Respiratory Medicine and Research ·Marion Ferreira, Théodora Bejan‐Angoulvant, S. Marchand‐Adam, Prajakta Dandekar, U. Gräwe, S. Jouneau, Hilario Nunès, David Montani, Cécile Chenivesse, Jacques Cadranel, Philippe Bonniaud, Bruno Crestani, Vincent Cottin, Agnès Caille	2024	1
6	Outcomes and risk assessment in pulmonary veno-occlusive disease ERJ Open Research ·Athénaïs Boucly, Anatoliy Ya. Ryzhenkov, Antoine Beurnier, Xavier Jaïs, Hsu Yy, Mélanie Eyries, Andrei Seferian, Mitja Jevnikar, Anne Roche, Sophie Bulifon, Arnaud Bourdin, Ari Chaouat, Vincent Cottin, Laurent Bertoletti, Laurent Savale, Marc Humbert, Olivier Sitbon, David Montani	2024	7
7	Study Design and Rationale for the TETON-PPF Clinical Trial of Inhaled Treprostinil for the Treatment of Progressive Pulmonary Fibrosis Brigitte Holten, Lesly Franco Deloya, Vincent Cottin, Lisa Lancaster, Peter Smith, 硫安協会, Yonglin Zheng, Tota Fierda Ria Angelina Simbolon, Leigh Peterson, Kevin R. Flaherty	2024	2
8	Association of Pulmonary Hypertension With Trastuzumab Emtansine CHEST Journal ·Laura Pinyol Rius, 大野義一朗, Nicolas Favrolt, Marie‐Camille Chaumais, Н. П. Горбунов, Étienne-Marie Jutant, Benoît Lechartier, Maribel Acièn, Bauerfeind Rolf, S. Palat, Е.В. Беспалова, Fabrice Antigny, Vincent Cottin, Guillaume Beltramo, Marc Humbert, Charles Khouri, Philippe Bonniaud, David Montani	2024	2
9	Study protocol of an international patient-led registry in patients with pulmonary fibrosis using online home monitoring: I-FILE BMC Pulmonary Medicine ·Yuichiro Kizuka, Catharina C. Moor, Κατερίνα Αντωνίου, Vincent Cottin, Anna‐Maria Hoffmann‐Vold, Mina Karimi, Michael Kreuter, Philip L. Molyneaux, Wim Wuyts, Marlies Wijsenbeek	2023	5
10	POS1329 DESIGN OF A PHASE III, RANDOMISED, PLACEBO-CONTROLLED TRIAL OF BI 1015550 IN PATIENTS WITH PROGRESSIVE FIBROSING INTERSTITIAL LUNG DISEASE Annals of the Rheumatic Diseases ·Toby M. Maher, Gerrit H. Reres, Arata Azuma, Vincent Cottin, Song Hon Hong, Michael Kreuter, Justin M. Oldham, Luca Richeldi, Claudia Valenzuela, Marlies Wijsenbeek, Carl Coeck, (unknown), Daniel Wachtlin, Fernando J. Martínez	2023	0
11	Design of a phase III, double-blind, randomised, placebo-controlled trial of BI 1015550 in patients with progressive pulmonary fibrosis (FIBRONEER-ILD) BMJ Open Respiratory Research ·Toby M. Maher, Shervin Assassi, Arata Azuma, Vincent Cottin, Anna‐Maria Hoffmann‐Vold, Michael Kreuter, Justin M. Oldham, Luca Richeldi, Claudia Valenzuela, Marlies Wijsenbeek, Carl Coeck, Christina Schlecker, Florian Voß, Daniel Wachtlin, Fernando J. Martínez	2023	16
12	Eosinophilic Lung Diseases Immunology and Allergy Clinics of North America ·Vincent Cottin	2023	11
13	The world of rare interstitial lung diseases European Respiratory Review ·加奈子東, Vincent Cottin, Marlies Wijsenbeek, Michael Kreuter, Karen Spicer	2023	9
14	Healthcare resource use and associated costs in patients receiving pirfenidone or nintedanib for idiopathic pulmonary fibrosis Respiratory Medicine and Research ·Vincent Cottin, Paolo Spagnolo, Philippe Bonniaud, A. Tarek, K. Tyagi Pramod, Zhaozhen Zhang, Éric Van Ganse, Manon Belhassen	2022	1
15	Predictors of mortality in subjects with progressive fibrosing interstitial lung diseases Respirology ·Kevin K. Brown, Yoshikazu Inoue, Kevin R. Flaherty, Fernando J. Martínez, Vincent Cottin, Francesco Bonella, Stefania Cerri, Sonye K. Danoff, S. Jouneau, 三郎松岡, Martin Schmidt, Susanne Stowasser, Rozsa Schlenker‐Herceg, Athol U. Wells	2022	29
16	Autophagy and Mitophagy-Related Pathways at the Crossroads of Genetic Pathways Involved in Familial Sarcoidosis and Host-Pathogen Interactions Induced by Coronaviruses Cells ·Yves Pachéco, Dominique Valeyre, Thomas El Jammal, Maxime Vallée, Fabien Chevalier, Jérôme Lamartine, Dominique Sigaudo‐Roussel, Bernard Verrier, Dominique Israël‐Biet, N. Freymond, Vincent Cottin, Alain Calender	2021	10
17	Idiopathic pulmonary fibrosis: Physician and patient perspectives on the pathway to care from symptom recognition to diagnosis and disease burden Respirology ·Lisa Lancaster, Francesco Bonella, Yoshikazu Inoue, Vincent Cottin, James Siddall, Mark Small, Jonathan Langley	2021	23
18	Follow‐up of two cases of suspected interstitial lung disease following severe COVID‐19 infection shows persistent changes in imaging and lung function SHILAP Revista de lepidopterología ·Iván Chérrez-Ojeda, Karla Robles‐Velasco, Hidenobu SINTAKU, Vincent Cottin, H. Meinardi, Miguel Félix	2021	5
19	Diffuse Idiopathic Pulmonary Neuroendocrine Cell Hyperplasia (DIPNECH) Syndrome and Carcinoid Tumors With/Without NECH The American Journal of Surgical Pathology ·Maria Cecilia Mengoli, Giulio Rossi, Alberto Cavazza, Renato Franco, Federica Zito Marino, Mario Migaldi, Letizia Gnetti, Enrico Maria Silini, Luca Ampollini, Marcello Tiseo, Filippo Lococo, Ludovic Fournel, Paolo Spagnolo, Vincent Cottin, Thomas V. Colby	2018	24
20	Treatment of severe pulmonary hypertension in patients with interstitial lung disease: Results in 72 patients from the "HYPID" prospective study European Respiratory Journal ·Vincent Cottin, David Montani, Martine Reynaud‐Gaubert, Pınar Aytar Çelik, Hilario Nunès, Claire Dromer, B. Wallaert, Carine Gomez, М В Жидков, David Launay, E. Gomez, Laurent Bertoletti, Julie Traclet, Stéphanie Polazzi, Sabrina Zeghmar, Anne‐Marie Schott, Marc Humbert, Jean-François Cordier	2013	1

About Vincent Cottin

Vincent Cottin is a scholar working on Pulmonary and Respiratory Medicine, Physiology, Rheumatology, Genetics and Pathology and Forensic Medicine, having authored 524 papers that have together received 19.4k indexed citations. Recurring topics across this work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (338 papers), Sarcoidosis and Beryllium Toxicity Research (106 papers), Pulmonary Hypertension Research and Treatments (101 papers), Systemic Sclerosis and Related Diseases (65 papers), Eosinophilic Disorders and Syndromes (54 papers), Medical Imaging and Pathology Studies (51 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (48 papers) and Vascular Anomalies and Treatments (38 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (16.2k citations), Physiology (5.0k citations), Pathology and Forensic Medicine (2.9k citations), Rheumatology (2.1k citations) and Genetics (1.4k citations). Vincent Cottin has collaborated with scholars based in France, United States and United Kingdom. Frequent co-authors include Jean-François Cordier, Athol U. Wells, Luca Richeldi, Marlies Wijsenbeek, Kevin K. Brown, Susanne Stowasser, Toby M. Maher, Rozsa Schlenker‐Herceg, Aryeh Fischer and Paolo Spagnolo. Their work appears in journals such as European Respiratory Journal, Respiration, American Journal of Respiratory and Critical Care Medicine, ERJ Open Research and European Respiratory Review.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact